Streptavidin as a Scaffold for Light-Induced Long-Lived Charge Separation by Keller, Sascha G. et al.
	 1	
Streptavidin	as	a	Scaffold	for	Light-Induced	Long-
Lived	Charge	Separation	
Sascha	G.	Keller,[a]	Andrea	Pannwitz,[b]	Hendrik	Mallin,[a]	Oliver	S.	Wenger*,[b]	and	Thomas	R.	
Ward*,[a]	
[a]	 Department	of	Chemistry,	University	of	Basel,	Spitalstrasse	51,	CH-4056	Basel,	
Switzerland,	thomas.ward@unibas.ch	
[b]	 Department	of	Chemistry,	University	of	Basel,	St.	Johanns-Ring	19,	CH-4056	Basel,	
Switzerland,	oliver.wenger@unibas.ch	
	
1.	Abstract	
Long-lived	 photo-driven	 charge	 separation	 is	 demonstrated	 by	 assembling	 a	 triad	 on	 a	
protein	 scaffold.	 For	 this	 purpose,	 a	 biotinylated	 triarylamine	 was	 added	 to	 a	 Ru(II)-	
streptavidin	conjugate	bearing	a	methyl	viologen	electron	acceptor	covalently	linked	to	the	
N-terminus	 of	 streptavidin.	 To	 improve	 the	 rate	 and	 lifetime	 of	 the	 electron	 transfer	 a	
negative	 patch	 consisting	 of	 up	 to	 three	 additional	 negatively	 charged	 amino	 acids	 was	
engineered	 via	 mutagenesis	 close	 to	 the	 biotin-binding	 pocket	 of	 streptavidin.	 Time-
resolved	laser	spectroscopy	revealed	that	the	covalent	attachment	and	the	negative	patch	
were	 beneficial	 for	 charge	 separation	 within	 the	 streptavidin	 hosted	 triad:	 the	 charge	
separated	 state	 was	 generated	 within	 the	 duration	 of	 the	 excitation	 laser	 pulse,	 and	
lifetimes	up	to	3120	ns	could	be	achieved	with	the	optimized	supramolecular	triad.	
	
2.	Introduction	 	
In	 nature,	 the	 multicomponent	 photosystems	 II	 and	 I	 (PS	 II,	 PS	 I)	 harvest	 the	 energy	
provided	 by	 the	 sun	 and	 convert	 it	 into	 cellular	 fuel	 NADH.	 In	 plant	 photosynthesis,	 the	
electrons	for	the	reduction	of	NAD+	to	NADH	are	provided	by	the	oxidation	of	water,	on	the	
other	 side	 of	 the	 enzyme	 complex.[1]	 Upon	 light	 absorption,	 water	 is	 oxidized	 and	 the	
electrons	are	transferred	via	a	cascade	to	the	catalytic	reduction	site.	All	redox	and	electron	
transfer	 processes	 take	 place	 in	 specific	 and	 specialized	 protein	 environments.	 In	 a	
biomimetic	 spirit,	 artificial	 photosynthesis	 aims	 at:	 i)	 mimicking	 the	 performance	 and	
functionality	 of	 natural	 photosynthesis,	 ii)	 converting	 visible	 light	 into	 electrochemical	
energy	 and	 iii)	 storing	 the	 extracted	 energy	 as	 chemical	 fuels.	 To	 achieve	 this	 ambitious	
goal,	 the	 generation	 of	 long-lived	 charge-separated	 states	 is	 essential.	 If	 the	 resulting	
electron-hole	pair	recombination	is	slow,	the	produced	generated	potential	can	be	valorized	
to	drive	chemical	reactions.	 In	the	past	 forty	years,	significant	effort	has	been	 invested	by	
chemists	 to	 mimic	 the	 exquisitely	 complex	 photosynthetic	 reaction	 center.[2–5]	 For	 this	
purpose,	 covalent	 or	 supramolecular	 assembly	 of	 an	 electron	 acceptor	 (A),	 an	 electron	
donor	 (D)	 and	 a	 photosensitizer	 (PS)	 affords	 an	 artificial	 triad	 A—PS—D.[6,7]	 Upon	
photochemical	 irradiation,	 the	 excited	 state	 A—PS*—D	 can	 react	 to	 afford	 the	
corresponding	(transient)	charge-separated	species	A——PS—D+.	 In	a	biomimetic	spirit,	we	
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set	out	 to	exploit	a	protein	 scaffold	 to	position	all	 three	components	of	an	artificial	 triad.	
There	are	 few	examples	of	artificial	dyads	embedded	within	proteins	or	peptides;[8–16]	but	
artificial	 intramolecular	triads	relying	on	a	protein	scaffold	seem	unexplored	to	the	best	of	
our	knowledge.		
We	selected	streptavidin	(Sav	hereafter)	as	a	scaffold	for	the	assembly	of	such	a	triad.	Sav	is	
a	remarkably	stable	and	versatile	homotetrameric	protein	(4	⋅	159	aminoacids,	ca.	65	kDa).	
Each	 of	 the	 four	 identical	 monomers	 can	 bind	 one	 equivalent	 of	 biotin	 with	 a	
supramolecular	binding	affinity	of	KA	=	ca.	1013	M-1.[17]	The	biotin-(strept)avidin	technology,	
commonly	referred	to	as	molecular	velcro,	draws	its	versatility	from	the	remarkable	affinity	
between	 biotinylated	 probes	 and	 (strept)avidin.	 Importantly,	 derivatization	 of	 the	
carboxylate	of	biotin	by	 large	probes	does	not	affect	 significantly	 this	 remarkable	affinity.	
Since	 its	 introduction	 by	 Bayer	 and	 Wilchek	 half	 a	 century	 ago,	 it	 has	 found	 numerous	
applications	 in	 live	cell	 imaging,	drug	delivery,	ELISA	and	pull-down	assays.[17]	Additionally,	
this	 technology	was	 used	 in	 the	 past	 decade	 to	 anchor	 abiotic	 cofactors	within	 a	 protein	
environment	to	create	artificial	metalloenzymes.[18–28]	
This	effort	was	inspired	by	a	visionary	publication	by	Whitesides.[23,29–33]	In	a	related	context,	
several	studies	on	the	luminescence	properties	of	(strept)avidin-embedded	biotinylated	d6-
metal	 complexes,	 including	 ruthenium(II)	 polypyridines,[34–37]	 rhenium(I)	 tricarbonyl	
diimines[38–42]	 and	 cyclometalated	 iridium(III)	 complexes[43–48]	 suggest	 that	 such	 protein-
based	systems	are	well-suited	for	the	generation	of	photo-induced	charge	separation.[49]	
In	 a	 recent	 study,[50]	 we	 covalently	 anchored	 [Ru(bpy)2(phenNHCOCH2Br)](PF6)2	 to	 four	
different	 Sav	 isoforms	 bearing	 a	 single	 cysteine	 residue	 per	 monomer	 (Figure	 1).	 Upon	
addition	 of	 a	 biotinylated	 triarylamine	 Biot-TAA,	 acting	 as	 electron	 donor,	 and	 excess	
methyl	 viologen	MV2+	 as	 external	 electron	 acceptor,	 we	 could	 characterize,	 by	 transient	
absorption	 spectroscopy,	 the	 formation	 of	 charge-separated	 species	 by	 photoinduced	
electron	transfer.		
	
	
Figure	1:	Structures	of	the	photosensitizer,	the	donor	and	the	acceptor	used	with	cysteine-
bearing	 Sav	 mutants	 to	 create	 Sav-embedded	 triads.	 Cysteine-bound	 ruthenium(II)	
photosensitizer,	 (RuSav);	 biotinylated	 triarylamine	Biot-TAA	 (biotin	 in	 blue),	 the	TAA-NH2	
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used	as	reference,	methyl	viologen	MV2+	and	the	methyl	viologen	analogue	aMV2+	that	was	
covalently	bound	to	the	N-terminus	of	Sav	to	afford	RuSav—aMV2+	(see	SI	for	synthesis	and	
characterization).	
	
By	varying	the	position	of	 the	[Ru(diimine)3]2+	photosensitizer	on	the	Sav	scaffold	 (i.	e.	by	
testing	four	different	cysteine-bearing	Sav	mutants),	we	could	identify	the	most	suitable	Sav	
mutant	that	favored	an	efficient	electron	transfer,	as	detected	by	the	photoproduct	of	the	
oxidized	 electron	 donor.	 To	 ensure	 efficient	 electron	 transfer	 however,	 the	 terminal	
acceptor	MV2+	was	 added	 in	 a	 large	 excess	 to	 the	 solution	 containing	 the	 Sav-embedded	
dyad.[50]		
Building	 on	 these	 results,	 we	 report	 herein	 on	 our	 efforts	 to	 assemble	 and	 optimize	 a	
supramolecular	triad	embedded	within	a	streptavidin	scaffold.	
	
3.	Results	&	Discussion	
Synthesis	and	structural	aspects	
In	order	to	 improve	the	rate	of	the	electron	transfer	as	well	as	the	 lifetime	of	the	charge-
separated	 species,	we	hypothesized	 that	we	may	be	able	 to	 combine	both	 chemical-	 and	
genetic	optimization	strategies	to	assemble	within	streptavidin	a	triad.[18]	With	this	goal	 in	
mind,	we	set	out	to	covalently	anchor	aMV2+	to	the	N-terminus	of	Sav.	We	speculated	that	
this	 strategy	would	 increase	 the	 effective	molarity	 of	 the	 terminal	aMV2+	acceptor	 in	 the	
proximity	of	the	biotinylated	donor	Biot-TAA	embedded	within	the	Sav	bearing	a	covalently-
bound	photosensitizer.	The	resulting	Sav-embedded	triad,	abbreviated	Biot-TAA	 ⋅ 	RuSav—
aMV2+,	 was	 further	 optimized	 by	 genetic	 means.	 We	 hypothesized	 that	 engineering	 an	
anionic	 patch	 in	 the	proximity	 of	 the	biotin-binding	 vestibule	 (hosting	both,	 the	Biot-TAA	
and	 the	 [Ru(diimine)3]2+-moiety)	may	contribute	 to	 further	 increase	 the	effective	molarity	
of	 the	 terminal	 electron	 acceptor	 in	 the	 proximity	 of	 both	 photosensitizer	 and	 electron	
donor.	This	concept	has	been	used	by	nature,	where	an	accumulation	of	negatively	charged	
amino	acids	(negative	patch)	on	plastocyanin	are	proposed	to	be	involved	in	recognition	of	
physiological	reaction	partners	as	cytochrome	f	and	Photosystem	I.[51–53]	The	effect	of	both	
chemical	 and	 genetic	 optimizations	 of	 the	 triad	 was	 evaluated	 relying	 on	 time-resolved	
photo-excitation	experiments.	
	
The	 ruthenium(II)	 complex	 [Ru(bpy)2(phenNHCOCH2Br)](PF6)2,	 the	 biotinylated	
supramolecular	binding	partner	triarylamine	Biot-TAA	and	the	reference	triarylamine	TAA-
NH2	 were	 synthesized	 as	 previously	 described	 (Figure	 1).[50]	 The	 alkoxy-amine	 containing	
methyl	viologen	analogue	aMV2+	was	synthesized	in	4	steps	as	detailed	in	the	SI	(Scheme	S1	
and	 Figures	 S1-S7).	 As	 previously	 demonstrated,[50]	 the	 dyad	 bearing	 the	 ruthenium	
photosensitizer	covalently	anchored	at	position	K121C	of	Sav	displayed	the	highest	quantum	
yield	 of	 the	 oxidized	Biot-TAA.	We	 thus	 selected	 K121C	 Sav	 as	 a	 starting	 scaffold	 for	 all	
mutagenesis	studies	reported	herein.	Inspection	of	the	X-ray	structure	of	the	mature	S112A	
Sav	 (pdb	 code:	 3PK2)[54]	 revealed	 a	 disordered	 N-terminus	 (i.e.	 residues	 2-12,	
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ASMTGGQQMGR).	 These	 residues	 were	 modelled	 using	 Yasara[55]	 and	 possessed	 an	 α-
helical	structure.	To	flexibilize	this	N-terminus,	thus	 increasing	the	probability	bringing	the	
aMV2+	closer	to	the	PS,	we	substituted	the	-QQMGRD-	motif	(residues	9-14)	by	a	-SGGGGS-	
sequence	(N-flex	hereafter).	
	
In	a	 second	 step,	 to	evaluate	 the	effectiveness	of	a	negative	patch	 to	bring	 the	positively	
charged	aMV2+	 in	 the	 proximity	 of	 the	 biotin-binding	 vestibule,	we	 engineered	 additional	
glutamate	and	aspartate	residues	at	positions	N82-Y83-R84	(Figure	2	and	Figure	S8).	These	
three	residues	were	identified	using	Yasara[55]	as	suitably	positioned	to	allow	the	aMV2+	to	
reach	the	negative	patch	generated	upon	incremental	introduction	of	Glu	or	Asp	residues	at	
these	positions	(Figure	2).	
	
	
		
Figure	 2:	 Engineering	 a	 negative	 patch	 in	 the	 proximity	 of	 the	 biotin	 binding	 vestibule.	
Surface	 representation	 of	 homotetrameric	 streptavidin,	 highlighting	 the	 selected	 amino	
acids	 (N82-Y83-R84,	 red)	 for	 the	 introduction	 of	 a	 negative	 patch;	 the	 K121C	 position	
(yellow)	 for	 the	 introduction	 of	 the	 Ru(II)	 photosensitizer,	 the	 naturally	 occurring	 E51	
(orange)	 as	 well	 as	 biotin	 (blue,	 stick	 representation)	 (S112A	mutant,	 the	 organometallic	
cofactor	bound	to	the	biotin	was	removed	due	to	clarity,	pdb:	3PK2).[54]	
	
We	 mutated,	 expressed	 and	 purified	 four	 different	 mutants	 using	 N-flex	 K121C	 Sav	 as	
template	with	either	no	 (Sav0	 hereafter),	one	 (Sav1	 hereafter,	R84E),	 two	 (Sav2	 hereafter,	
N82D-R84E)	or	 three	 (Sav3	 hereafter,	N82D-Y83E-R84E)	 additional	 carboxylate	 side	 chains	
(Figure	 2).	 As	 the	 WT	 Sav	 contains	 a	 glutamate	 E51	 in	 the	 proximity	 of	 the	 engineered	
negative	patch,	up	to	 four	negative	charges	may	be	present	 in	 the	case	of	 the	N-flex-Sav3	
mutant	(highlighted	in	orange	and	red	in	Figure	2).	The	mutants	were	expressed	using	ZYP-
5052	media,	 purified	 by	 affinity	 chromatography	 using	 iminobiotin-sepharose	matrix	 and	
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characterized	by	ESI-MS	(details	collected	in	the	SI,	Figures	S10-S17).[56,57]	SDS-PAGE	analysis	
using	biotin-4-fluorescein	demonstrated	the	biotin	binding	capability	of	the	engineered	Sav	
tetramers	and	highlighted	a	marked	 change	 in	 its	 isoelectric	point	pI	 as	evidenced	by	 the	
significant	difference	in	electrophoretic	mobility	(Figure	S9).		
	
To	 covalently	 link	 the	methyl	 viologen	 analogue	aMV2+	 to	 Sav's	N–terminus,	 the	 versatile	
procedure	 developed	 by	 Francis	 et	 al.	 was	 slightly	 modified,	 Figure	 3.[58]	 The	 procedure	
tolerated	 the	 use	 of	 pyridoxal-5-phosphate	 PLP	 which,	 added	 in	 excess	 to	 a	 phosphate-
buffered	solution	(50	mM,	pH	6.5)	of	the	RuSav,	resulted	in	the	oxidation	and	hydrolysis	of	
the	N-terminal	amine	group	to	a	ketone	(Figure	3).		
	
	
Figure	3:	Coupling	a	modified	activated	methyl	viologen	aMV2+	to	the	N-terminus	of	RuSav	
via	 a	 pyridoxal-5-phosphate-mediated	 transformation	 to	 yield	 the	 methyl	 viologen	
containing	conjugate	RuSav—aMV2+.	 (a)	0.2	M	PLP,	50	mM	PO43-	buffer,	pH	6.5,	37°C,	1	h	
(b)	250	mM	aMV2+,	50	mM	PO43-	buffer,	pH	2.2,	37°C,	1.5	h.	
	
After	 removal	 of	 excess	 PLP	 by	 ultrafiltration	 dialysis	 (10	 kDa	 cut	 off),	 the	 resulting	 Sav	
bearing	a	 single	ketone	 functionality	 readily	 reacted	with	 the	alkoxyamine-bearing	aMV2+,	
added	 in	 excess	 to	 a	 phosphate-buffered	 solution	 (50	mM,	 pH	 2.2).	 The	 resulting	 oxime	
linkage	is	stable	towards	hydrolysis.	The	reaction	was	performed	for	one	hour	at	37°C	and	
the	resulting	bioconjugates	were	purified	via	dialysis.	Hereafter,	we	refer	to	the	engineered	
Sav	 bioconjugates	 bearing	 the	 covalently	 attached	 [Ru(diimine)3]2+-photosensitizer	 as	
RuSavn	and	the	covalently	modified	aMV2+	as	RuSavn—aMV2+	(where	n	=	0,	1,	2	or	3).		
Since	no	crystal	structure	could	be	obtained	so	far,	through-space	distances	were	estimated	
based	on	a	previously	published	crystal	structure	of	an	 Ir-loaded	streptavidin	mutant	(pdb	
code:	 3PK2).[54]	 In	 a	 similar	 fashion	 to	 our	 previous	 study,[50]	 the	 arylated	 biotin	 moiety	
bearing	a	para-sulfur	atom	was	used	for	distance	estimation	(Figure	S18	and	Table	S1).	This	
latter	sulfur	atom	was	selected	as	a	surrogate	for	the	nitrogen	atom	of	the	Biot-TAA	moiety.	
The	through-space	distances	from	the	sulfur	atom	to	the	α-carbons	of	the	K121	residues	can	
be	estimated	to	7.1	Å	and	8.6	Å	respectively.	The	through	space	distances	of	the	α-carbons	
of	the	K121	residues	and	the	α-carbons	of	the	closest	negatively	charged	R84	residues	were	
determined	 to	be	18.7	Å	and	22.0	Å	 respectively.	 Furthermore,	 the	distances	of	 the	Biot-
TAA	itself	and	the	negative	patches	are	14.8	Å	and	21.7	Å	respectively.	Given	the	flexibility	
of	the	system	those	are	rough	estimates.	
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The	 biotin-binding	 capacity	 of	 the	 RuSavn	 and	 the	 RuSavn—aMV2+	 bioconjugates	 was	
evaluated	 relying	 on	 a	 displacement	 titration	 using	 2-(4-hydroxyphenylazo)benzoic	 acid	
(HABA).[22,57,59]	 Upon	 incorporation	within	 Sav,	HABA	displays	 an	 absorption	 at	 λmax	 =	 506	
nm.	Addition	of	a	biotinylated	probe	displaces	HABA,	thus	leading	to	the	disappearance	of	
the	absorption	band	at	506	nm.	This	 straightforward	procedure	 revealed	 that	each	of	 the	
four	 biotin-binding	 sites	 of	 the	 homotetrameric	 Sav	 bioconjugates	 can	 accommodate	 one	
biotinylated	cofactor	Biot-TAA	(Figure	S19	and	S20).	Moreover,	the	affinity	of	Biot-TAA	for	
RuSavn	or	RuSavn—aMV2+	(where	n	=	0	-	3)	is	comparable	to	that	of	biotin	for	WT	Sav.	This	
confirms	 that	 the	 bulky	 Biot-TAA	 moieties	 tightly	 bind	 to	 RuSavn	 and	 RuSavn—aMV2+	
isoforms,	 despite	 the	 presence	 of	 the	 bulky	 [Ru(diimine)3]2+	 moiety	 which	 lies	 in	 the	
immediate	proximity	of	the	biotin-binding	vestibule.	
	
Optical	spectroscopic	studies	
UV/Vis	 transient	 absorption	 spectroscopy	 was	 used	 to	 explore	 photo-induced	 electron	
transfer	 in	 the	 streptavidin-based	 donor-photosensitizer-acceptor	 systems.	 Selective	
photoexcitation	of	the	Ru(II)	chromophore	of	the	RuSavn—aMV2+	·	Biot-TAA	systems	at	450	
nm	with	laser	pulses	of	∼10	ns	duration	under	deaerated	conditions	in	milliQ	water	lead	to	
the	transient	absorption	spectra	displayed	in	Figure	4.		
 	
Figure	4:	Transient	absorption	spectra	of	50	µM	of	RuSav0—aMV2+	(black	trace),	RuSav1—
aMV2+	 (blue	 trace),	RuSav2—aMV2+	 (green	 trace)	and	RuSav3—aMV2+	 (red	 trace)	 in	milliQ	
water	 at	 25	 °C,	 10	µs	 after	 excitation	at	 450	nm	 in	presence	of	 50	µM	Biot-TAA.	 Spectra	
were	time-integrated	over	4	µs.	
The	red	trace	in	Figure	4,	recorded	with	a	time	delay	of	10	µs	for	the	RuSav3—aMV2+	·	Biot-
TAA	 system,	exhibits	 the	spectroscopic	 signatures	expected	 for	electron	 transfer	between	
the	TAA	/	MV2+	couple.	In	particular,	the	narrow	intense	band	at	around	400	nm	as	well	as	
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the	weaker	(broad)	absorption	around	605	nm	are	diagnostic	for	MV+,[60,61]	while	the	band	
at	750	nm	 is	characteristic	 for	TAA+.[62,63]	Nearly	 identical	 transient	absorption	spectra	are	
obtained	for	RuSav2—aMV2+	 ·	Biot-TAA	 (green	trace)	and	RuSav1—aMV2+	 ·	Biot-TAA	 (blue	
trace),	i.	e.,	the	systems	having	only	two	or	one	single	point	mutations	(instead	of	three)	to	
introduce	additional	negative	charge	on	the	protein	surface.	Only	the	RuSav0—aMV2+	·	Biot-
TAA	 system	 (black	 trace)	without	 any	mutations	 produces	weaker	 TAA+	 and	MV+	 signals.	
The	clear	message	extracted	from	these	experiments	is	that	long-lived	charge-separation	is	
readily	achievable	based	on	this	design	principle.	Importantly,	point	mutations	that	increase	
the	negative	charge	on	the	streptavidin	surface	are	beneficial	for	formation	of	the	desired	
photoproducts	comprised	of	TAA+	/	MV+	pairs.	
The	 quaternary	 structure	 of	 Sav	 consists	 of	 four	 sub-units	 that	 all	 harbour	 one	
[Ru(diimine)3]2+	photosensitizer,	one	TAA	donor,	and	one	methyl	viologen	acceptor.	Thus,	
all	 our	RuSavn—aMV2+	 ·	Biot-TAA	 systems	 are	 conformationally	 flexible	 tetrads	 of	 triads,	
and	 this	 complicates	 the	 kinetic	 analysis	 for	 two	 obvious	 reasons:	 (i)	 conformational	
flexibility	 leads	 to	 multiple	 donor-sensitizer,	 sensitizer-acceptor,	 and	 donor-acceptor	
distances	in	different	proteins	and	its	sub-units;	(ii)	electron	transfer	can	also	occur	between	
redox-active	 units	 attached	 to	 different	 sub-units	 of	 Sav.	 Consequently,	 given	 the	
uncontrollable	 multitude	 of	 electron	 transfer	 distances	 and	 pathways,	 multi-exponential	
kinetics	for	formation	and	decay	of	the	photoproducts	are	generally	observed,	unlike	in	rigid	
rod-like	 donor-sensitizer-acceptor	 compounds.	 It	 is	 thus	 not	 possible	 to	 extract	 rate	
constants	for	every	 individual	photo-initiated	processes	 in	our	streptavidin-based	scaffolds	
in	a	meaningful	manner.	
The	 general	 observation	 for	 the	 RuSavn—aMV2+	 ·	 Biot-TAA	 systems	 is	 that	 a	 substantial	
amount	of	TAA+	photoproduct	(absorbing	at	750	nm)	is	formed	within	the	10	ns	duration	of	
the	laser	pulse	(Figure	S21),	indicating	that	in	a	subset	of	triads	electron	transfer	from	TAA	
to	the	photo-excited	[Ru(diimine)3]2+	complex	takes	place	with	rate	constants	(k)	exceeding	
108	s-1.	However,	 transient	absorption	spectra	recorded	 immediately	after	photoexcitation	
are	dominated	by	the	signature	of	the	3MLCT	state	of	the	photosensitizer	(Figure	S22),	and	
based	on	this	observation,	we	estimate	that	the	subset	undergoing	photo-induced	electron	
transfer	amounts	 to	 roughly	10%	at	most	under	 the	conditions	used	 for	our	experiments.	
Time-resolved	 luminescence	data	(Figure	S23)	monitoring	[Ru(diimine)3]2+	emission	at	630	
nm	confirm	that	the	3MLCT	excited-state	is	only	partially	quenched	in	the	RuSavn—aMV2+	·	
Biot-TAA	 systems.	 The	 disappointingly	 low	 yield	 for	 TAA+	 /	MV+	 photoproduct	 formation	
likely	 has	 the	 following	 reasons:	 Electrostatic	 repulsion	 between	 the	 [Ru(diimine)3]2+	
complex	and	the	MV2+	unit	in	the	conformationally	flexible	scaffolds	is	expected	to	lead	to	
large	 [Ru(diimine)3]2+-MV2+	 distances,	 disfavouring	 oxidative	 [Ru(diimine)3]2+	 3MLCT	
excited-state	 quenching.	 Most	 of	 the	 3MLCT	 quenching	 therefore	 likely	 occurs	 via	 a	
reductive	 pathway,	 i.	 e.,	 electron	 donation	 from	 TAA.	 Within	 the	 subset	 of	 scaffolds	
undergoing	primary	electron	 transfer	 from	TAA	 to	photo-excited	 [Ru(diimine)3]2+,	 onward	
electron	transfer	from	[Ru(diimine)3]+	to	MV2+	is	exergonic	by	-0.9	eV,	but	reverse	electron	
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transfer	 from	 [Ru(diimine)3]+	 to	 TAA+	 is	 thermodynamically	 even	 more	 favoured.[61-63]	
Indeed,	 the	 transient	 absorption	 kinetics	 in	 Figure	 S24	 suggest	 that	 58-71%	 of	 the	 TAA+	
signal	at	750	nm	decay	very	rapidly	after	the	laser	pulse	(τ	≈	20	ns;	Table	1	and	SI	Figures	
S21,	S22,	S24	and-S25),	and	this	is	attributed	to	thermal	reverse	electron	transfer	between	
[Ru(diimine)3]+	 and	 TAA+.	 Time-resolved	 luminescence	 data	 are	 compatible	 with	 this	
interpretation	(Figure	S26	and	Table	S2).	
Thus,	 in	 order	 to	 detect	 the	 TAA+	 /	MV+	 photoproducts	 resulting	 from	 complete	 electron	
transfer	as	cleanly	as	possible,	transient	absorption	spectra	were	generally	recorded	with	a	
long	delay	 time	 (10	µs)	using	 long	 integration	 times	 (4	µs).	After	10	µs,	unreacted	 3MLCT	
excited	states	have	decayed	through	common	radiative	and	non-radiative	pathways	and	do	
no	longer	contribute	to	the	transient	difference	spectra,	and	simple	[Ru(diimine)3]+	to	TAA+	
pairs	 have	 either	 recombined	 or	 undergone	 onward	 reaction	 to	 the	 desired	 TAA+	 /	MV+	
products.	Unfortunately,	this	leads	to	low	signal	to	noise	ratios	(Figure	4).	
Once	 the	 TAA+	 /	 MV+	 pairs	 have	 been	 formed,	 this	 charge-separated	 state	 decays	 on	 a	
microsecond	time	scale.	The	respective	transient	absorption	data	monitoring	the	decay	of	
TAA+	at	750	nm	(Figure	S21)	and	the	decay	of	MV+	at	400	nm	(Figure	S24)	can	be	fitted	in	bi-
exponential	fashion	for	all	four	RuSavn—aMV2+	·	Biot-TAA	systems,	with	one	time	constant	
in	the	range	of	225-287	ns	and	a	second	time	constant	between	1766	and	3120	ns	(Table	1).		
Table	1:	Decay	time	constants	(t1,	t2,	t3)	of	the	charge-separated	state	RuSavn—MV+	·	Biot-
TAA+	(n	=	0,	1,	2,	3)	extracted	from	triexponential	fits.	In	each	case,	there	was	an	initial	rapid	
decay	with	a	time	constant	(t1)	of	ca.	20	ns,	which	leads	to	a	rate	constant	of	5*107	s-1	for	
TAA+	 to	 Ru(bpy)3+	 (reverse)	 electron	 transfer	 as	 mentioned	 in	 the	 main	 text.	 The	 time	
constants	t2	and	t3	reflect	the	decay	of	the	TAA+	/	MV+	charge-separated	state.	
	 t1	[ns]	 t2	[ns]	 t3	[ns]	
RuSav0—aMV+	·	Biot-TAA+	 25	(71%)	 287	(21%)	 2375	(8%)	
RuSav1—aMV+	·	Biot-TAA+	 20	(62%)	 261	(25%)	 2380	(13%)	
RuSav2—aMV+	·	Biot-TAA+	 20	(58%)	 225	(25%)	 1766	(17%)	
RuSav3—aMV+	·	Biot-TAA+	 23	(60%)	 274	(26%)	 3120	(14%)	
	
The	 tethered	 triads	RuSavn—aMV2+	 ·	Biot-TAA,	whereby	 the	MV2+	 is	 covalently	 linked	 to	
RuSav,	 affords	 instantly	 after	 photo-excitation	 an	 electron	 transfer	 to	 afford	 the	
corresponding	TAA+	/	MV+	(Figure	S24)	in	a	subset	of	scaffolds.	The	charge	separate	state	for	
the	untethered	triad	on	the	other	hand	only	builds	over	time	(Figure	S25).	In	this	case,	MV2+	
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reduction	 is	 likely	 occurring	 from	 the	 long-lived	 3MLCT	 excited-state	 via	 a	 diffusion	
controlled	oxidative	quenching	pathway.	
In	 control	 experiments,	 we	 found	 that	 Biot-TAA	 is	 of	 key	 importance	 for	 the	 successful	
photo-generation	of	TAA+	/	MV+	pairs.	When	instead	TAA-NH2	 is	used	(i.	e.,	a	triarylamine	
compound	 lacking	 the	 biotin	 unit,	 Figure	 1),	 no	 TAA+	 is	 formed	 (Figure	 S27).	 Conversely,	
covalent	attachment	of	MV2+	was	not	essential	 for	a	photoproduct	 to	 form	eventually,	as	
long	 as	 a	 negative	 patch	 is	 engineered	 through	 point	 mutations	 in	 the	 proximity	 of	 the	
biotin-binding	vestibule.	Specifically,	in	the	RuSavn	systems	with	n	=	1	–	3,	MV+	formation	is	
readily	observable	 in	presence	of	only	1	equivalent	of	ordinary	 (untethered)	MV2+	 (Figure	
S28).		
This	 nicely	 illustrates	 the	 effectiveness	 of	 the	 engineered	 negative	 patch	 in	 attracting	 a	
cationic	 electron	 acceptor.	 In	 the	 RuSavn	 system	 with	 n	 =	 0,	 i.	 e.,	 the	 native	 Ru(II)-
bioconjugated	protein	without	negative	patch,	15	equivalents	of	untethered	MV2+	must	be	
added	in	order	to	photo-generate	a	comparable	amount	of	MV+	as	 in	the	RuSavn	mutants	
with	n	=	1	–	3	in	presence	of	only	1	equivalent	of	MV2+	(Figure	S29).	This	again	illustrates	the	
effectiveness	of	the	negative	patch	in	triggering	charge	transfer.		
Consequently,	when	adding	1	equivalent	of	Biot-TAA	to	the	RuSavn	systems	with	n	=	1	–	3,	
addition	 of	 one	 equivalent	 of	 untethered	 MV2+	 is	 sufficient	 for	 the	 photo-production	 of	
long-lived	 TAA+	 /	 MV+	 pairs	 (Figure	 S30)	 similar	 to	 what	 was	 observed	 above	 for	 the	
RuSavn—aMV2+	·	Biot-TAA	systems	in	which	MV2+	was	covalently	tethered	(Figure	4).	
Yet	the	combination	of	tethering	the	MV2+-moiety	and	implementing	the	negative	patch	is	
crucial	to	enable	instant	electron	transfer	within	the	triad.	When	methyl	viologen	is	added	
in	solution	and	a	negative	patch	(RuSav3)	is	present,	the	temporal	evolution	of	the	transient	
absorption	spectrum	at	400	nm	shows	that	the	MV+	signal	builds	up	rather	slowly	over	time	
(Figure	 5a).	 In	 contrast	 when	 no	 negative	 patch	 is	 present	 and	 the	 methyl	 viologen	 is	
tethered	 (RuSav0—aMV2+)	 a	 signal	 is	 instantly	 observable	 (Figure	 5b).	 In	 the	 optimized	
system	 (RuSav3—aMV2+)	 where	 the	 methyl	 viologen	 is	 tethered	 and	 a	 negative	 patch	 is	
present,	however,	 the	signal	 intensity	of	 the	 instantly	appearing	signal	at	400	nm	 is	more	
intense	 (Figure	 5c).	 This	 highlights	 that	 a	 combination	 of	 tethering	 an	 oxidant	 and	
engineering	a	negative	patch	to	increase	the	local	concentration	facilitates	electron	transfer	
on	a	protein	scaffold.	
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Figure	5:	Temporal	 evolution	of	 the	 transient	 absorption	 signal	 at	400	nm	of	 (a)	RuSav3	 ·	
Biot-TAA	 with	 1	 equivalent	 of	 MV2+	 in	 solution	 (b)	 RuSav0—aMV2+	 ·	 Biot-TAA	 and	 (c)	
RuSav3—aMV2+	 ·	Biot-TAA	 (black	 traces	 correspond	 to	 the	 recorded	 data	 and	 red	 traces	
represent	the	fitted	functions).	
	
	
4.	Summary	&	Conclusions	
Streptavidin	was	used	as	a	scaffold	for	donor-photosensitizer-acceptor	triad	assemblies	that	
lead	 to	 the	 formation	 of	 long-lived	 charge-separated	 states	 after	 photoexcitation	 in	 the	
visible	spectral	range.	This	is	more	commonly	achieved	in	rigid	rod-like	compounds	requiring	
multi-step	 syntheses	 and	 tedious	 purification	 procedures.12	 Our	 study	 highlights	 that	
streptavidin	 can	 serve	 as	 a	 platform	 for	 the	 straightforward	 assembly	 of	 suitable	 donors,	
photosensitizers,	and	acceptors.	The	effectiveness	of	the	biotin	anchor	group	for	anchoring	
of	 a	 triarylamine	 donor	 is	 no	 surprise	 given	 its	 known	 affinity	 for	 (strept)avidin,	 but	 the	
influence	 of	 the	 genetically	 engineered	 negative	 patch	 for	 binding	 of	 the	 cationic	methyl	
viologen	 acceptor,	 as	 well	 at	 the	 covalent	 attachment	 of	 the	 electron	 acceptor	 onto	 the	
protein	is	remarkable.	Exploitation	of	this	electrostatic	effect	could	become	a	general	design	
principle	for	attachment	of	artificial	redox	cofactors	or	small-molecule	catalysts	to	enzymes.	
Furthermore,	 with	 these	 anionic	 patches,	 addition	 of	 1	 equivalent	 of	 untethered	 methyl	
viologen	 is	 nearly	 as	 effective	 as	 addition	 of	 15	 equivalents	 of	methyl	 viologen	 to	 Ru(II)-
modified	 streptavidin	 without	 any	 negative	 patch.	 At	 present,	 the	 quantum	 yield	 for	
formation	of	electron	transfer	photoproducts	is	low,	but	this	could	potentially	be	improved	
by	 optimizing	 the	 driving-forces	 for	 the	 individual	 (energy-storing)	 electron	 transfer	 steps	
through	donor,	sensitizer,	and	acceptor	variation.		
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